News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,456 Results
Type
Article (41912)
Company Profile (333)
Press Release (665211)
Section
Business (210165)
Career Advice (2080)
Deals (36582)
Drug Delivery (100)
Drug Development (82848)
Employer Resources (171)
FDA (16490)
Job Trends (15360)
News (355487)
Policy (33832)
Tag
Academia (2574)
Alliances (51184)
Alzheimer's disease (1275)
Approvals (16440)
Artificial intelligence (157)
Bankruptcy (362)
Best Places to Work (11715)
Biotechnology (215)
Breast cancer (191)
Cancer (1391)
Cardiovascular disease (116)
Career advice (1741)
Cell therapy (285)
Clinical research (66232)
Collaboration (496)
Compensation (263)
COVID-19 (2612)
C-suite (110)
Data (1400)
Diabetes (174)
Diagnostics (6255)
Earnings (86577)
Employer resources (149)
Events (112865)
Executive appointments (402)
FDA (17172)
Funding (432)
Gene therapy (206)
GLP-1 (631)
Government (4453)
Healthcare (18875)
Infectious disease (2704)
Inflammatory bowel disease (115)
Interviews (320)
IPO (16616)
Job creations (4052)
Job search strategy (1488)
Layoffs (439)
Legal (8326)
Lung cancer (199)
Lymphoma (100)
Manufacturing (215)
Medical device (13297)
Medtech (13302)
Mergers & acquisitions (20117)
Metabolic disorders (470)
Neuroscience (1606)
NextGen Class of 2024 (6625)
Non-profit (4516)
Northern California (1701)
Obesity (268)
Opinion (207)
Patents (120)
People (58416)
Phase I (20511)
Phase II (29144)
Phase III (21855)
Pipeline (517)
Postmarket research (2651)
Preclinical (8730)
Radiopharmaceuticals (241)
Rare diseases (271)
Real estate (6240)
Regulatory (22511)
Research institute (2359)
Resumes & cover letters (358)
Southern California (1468)
Startups (3712)
United States (15332)
Vaccines (582)
Weight loss (196)
Date
Today (2)
Last 7 days (590)
Last 30 days (2366)
Last 365 days (35728)
2024 (35555)
2023 (40631)
2022 (51798)
2021 (56329)
2020 (54794)
2019 (47400)
2018 (35771)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27631)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (776)
Arizona (202)
Asia (40139)
Australia (6423)
California (3836)
Canada (1455)
China (311)
Colorado (174)
Connecticut (179)
Europe (85475)
Florida (535)
Georgia (135)
Illinois (394)
Indiana (232)
Maryland (633)
Massachusetts (3007)
Michigan (174)
Minnesota (291)
New Jersey (1117)
New York (1086)
North Carolina (760)
Northern California (1701)
Ohio (146)
Pennsylvania (929)
South America (1157)
Southern California (1468)
Texas (557)
Utah (109)
Washington State (406)
707,456 Results for "syndax pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo™
November 5, 2024
·
12 min read
Press Releases
Syndax Announces Participation at the Citi 2024 Global Healthcare Conference
November 27, 2024
·
1 min read
Business
Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors
Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the appointment of Aleksandra Rizo, M.D., Ph.D., to its Board of Directors.
May 15, 2024
·
6 min read
Press Releases
Syndax Announces Participation in November 2024 Investor Conferences
November 4, 2024
·
1 min read
Genetown
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - June 03, 2024
Syndax Pharmaceuticals announced that on June 1, 2024 the Company granted inducement awards to purchase up to 499,200 shares of common stock to fifty-three new employees under the Company’s 2023 Inducement Plan.
June 3, 2024
·
1 min read
Press Releases
Syndax Presents Positive Revuforj® (revumenib) Data in Acute Leukemias from Multiple Trials, Including the SAVE Combination and AUGMENT-101 Trials, at 66th ASH Annual Meeting
December 9, 2024
·
19 min read
Business
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
Syndax Pharmaceuticals, a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, reported its financial results for the quarter ended March 31, 2024, and provided a business update.
May 8, 2024
·
13 min read
Genetown
Syndax Announces Participation at the Goldman Sachs 45th Annual Global Healthcare Conference
Syndax Pharmaceuticals today announced that Michael A. Metzger, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024.
June 5, 2024
·
1 min read
Press Releases
Syndax to Host ASH Investor Event in Person and via Webcast on December 9, 2024
November 5, 2024
·
1 min read
Press Releases
Syndax Reports Third Quarter 2024 Financial Results and Provides Business Update
November 5, 2024
·
16 min read
1 of 70,746
Next
